Inhibition of plasma membrane Ca2+-ATPase by heparin is modulated by potassium

International Journal of Biochemistry and Cell Biology

Volumn 39, Issue 3, 2007, Pages 586-596

  Felix, Carla F ^a   Oliveira, Vanessa H ^a   Moreira, Otacilio C ^a   Mignaco, Julio A ^a   Barrabin, Hector ^a   Scofano, Helena M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Ca2+ ATPase; Heparin; Plasma membrane; Potassium; Sulfated polysaccharides

Indexed keywords

4 NITROPHENOL; 4 NITROPHENYLPHOSPHATE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATE; CALCIUM ION; HEPARIN; LITHIUM ION; PHOSPHATE; POLYSACCHARIDE SULFATE; POTASSIUM ION; UNCLASSIFIED DRUG; VANADIC ACID;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL MEMBRANE; CONTROLLED STUDY; CYTOSOL; ENZYME BINDING; ENZYME CONFORMATION; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME REGULATION; ERYTHROCYTE; NONHUMAN; PROTEIN FUNCTION; REGULATORY MECHANISM; STEADY STATE;

EID: 33846288324     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2006.10.010     Document Type: Article

References (84)

1. 2+-ATPase. The Journal of Biological Chemistry 263 (1988) 17548-17554
2. 2+-ATPase from plasma membranes studied by phosphorylation. The Journal of Biological Chemistry 265 (1990) 3789-3792
3. 2+ pump 4b and the proapoptotic tumor suppressor Ras-associated factor 1 (RASSF1). The Journal of Biological Chemistry 279 (2004) 31318-31328
4. Berman M.C. Slippage and uncoupling in P-type cation pumps: Implications for energy transduction mechanisms and regulation of metabolism. Biochimica and Biophysica Acta 1513 (2001) 95-121
5. Bjork T., and Lindahl U. Mechanism of the anticoagulant action of heparin. Molecular and Cellular Biochemistry 48 (1982) 161-182
6. Bobek B., and Kovarik J. Antitumor and antimethastatic effect of warfarin and heparin. Biomedicine and Pharmacotherapy 58 (2004) 213-219
7. Bobik A., and Campbell J.H. Vascular derived growth factors: Cell biology, pathophysiology and pharmacology. Pharmacological Reviews 45 (1993) 1-42
8. Bourin M.-C., and Lindahl U. Glycosaminoglycans and the regulation of blood coagulation. Biochemical Journal 289 (1993) 313-330
9. Capila I., and Linhardt R.J. Heparin-protein interactions. Angewandte Chemie International Edition 41 (2002) 390-412
10. Carafoli E. Calcium pump of the plasma membrane. Physiological Reviews 71 (1991) 129-153
11. Carafoli E. Biogenesis: Plasma membrane calcium ATPase. 15 years of work on the purified enzyme. FASEB Journal 8 (1994) 993-1002
12. 2+-pumping ATPase of heart-sarcolemma. The Journal of Biological Chemistry 258 (1983) 7305-7310
13. 2+ pump. European Journal of Biochemistry 221 (1994) 1103-1110
14. 2+-ATPase of sarcoplasmic reticulum as revealed by thapsigargin stabilization. Biochimica and Biophysica Acta 1289 (1996) 187-194
15. 2+-ATPase isoforms 2b and 4b interact promiscuously and selectively with members of the membrane-associated guanylate kinase family of PDZ (PSD95/Dlg/ZO-1) domain-containing proteins. The Journal of Biological Chemistry 276 (2001) 21594-21600
16. 2+-ATPase. The Journal of Biological Chemistry 266 (1991) 5736-5742
17. 2+-ATPase: ATP hydrolysis, ATP synthesis and heat production. FEBS Letters 406 (1997) 201-204
18. 2+ transport ATPase of sarcoplasmic reticulum. FEBS Letters 299 (1992) 33-35
19. 2+-transport ATPases by heparin. The Journal of Biological Chemistry 269 (1994) 14525-14529
20. De Meis L., Suzano V.A., and Inesi G. Functional interactions of catalytic site and transmembrane channel in the sarcoplasmic reticulum ATPase. The Journal of Biological Chemistry 265 (1990) 18848-18851
21. Fabiato A., and Fabiato F. Calculation programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells. Journal of Physiology 75 (1979) 463-505
22. Faisnner A., Clement A., Lochter A., Streit A., Mandl C., and Schachner M. Isolation of a neural chondroitin sulfate proteoglycan with neurite outgrowth promoting properties. The Journal of Cell Biology 126 (1994) 783-799
23. Fedarko N.S., and Conrad E. A unique heparan sulfate in the nuclei of hepatocytes: Structural changes with the growth state of the cells. The Journal of Cell Biology 102 (1986) 587-599
24. 2+-ATPase by ATP and acidic phospholipids. The Journal of Biological Chemistry 278 (2003) 22265-22271
25. Folkman J., and Klagsbrum M. Angiogenic factors. Science 235 (1987) 442-447
26. 1 conformation in dimethylsulfoxide. Biochimica and Biophysica Acta 1323 (1997) 291-298
27. Fugedi P. The potential of the molecular diversity of heparin and heparan sulfate for drug development. Mini Reviews in Medicinal Chemistry 3 (2003) 659-667
28. Ghosh T.K., Eis P.S., Mullaney J.M., Ebert C.L., and Gill D.L. Competitive, reversible, and potent antagonism of inositol 1,4,5-triphosphate-activated calcium release by heparin. The Journal of Biological Chemistry 263 (1988) 11075-11079
29. Guillemette G., Lamontagne S., Boulay G., and Mouillac B. Differential effects of heparin on inositol 1,4,5-triphosphate binding metabolism, and calcium release activity in the bovine adrenal cortex. Molecular Pharmacology 35 (1989) 339-344
30. Gunay N.S., and Linhardt R.J. Heparinoids: Structure, biological activities and therapeutic applications. Planta Medica 65 (1999) 301-306
31. 2+-ATPase by lanthanum. Biochemistry 35 (1996) 14917-14922
32. 2+-ATPase. The Journal of Biological Chemistry 315 (1996) 673-677
33. 2+-ATPase from plasma membrane. The Journal of Biological Chemistry 269 (1994) 10400-10406
34. Hill T.D., Berggren P., and Boynton A.L. Heparin inhibits inositol triphosphate-induced calcium release from permeabilized rat liver cells. Biochemical and Biophysical Research Communications 149 (1987) 897-901
35. Howell A.L., Taylor T.H., Miller J.D., Groveman D.S., Eccles E.H., and Zacharsky L.R. Inhibition of HIV-1 infectivity by low molecular weight heparin: Results of in vitro studies and a pilot clinical trial in patients with advanced AIDS. International Journal of Clinical and Laboratory Research 26 (1996) 124-131
36. Huntington J.A. Mechanisms of glycosaminoglycan activation of the serpins in hemostasis. Journal of Thrombosis and Haemostasis 1 (2003) 1535-1549
37. Ishihara M., Fedarko N.S., and Conrad E. Involvement of phosphatidylinositol and insulin in the coordinate regulation of protoheparan sulfate metabolism and hepatocyte growth. The Journal of Biological Chemistry 262 (1987) 4708-4716
38. 2+-ATPase isoform 4b binds to membrane-associated guanylate kinase (MAGUK) proteins via their PDZ (PSD-95/Dlg/ZO-1) domains. The Journal of Biological Chemistry 273 (1988) 1591-1595
39. Kjellen L., and Lindahl U. Proteoglycans: Structures and interactions. Annual Review of Biochemistry 60 (1991) 443-475
40. 2+ channels by fluorescent dihidropyridines: Evidence for a functional, extracellular heparin-binding site. Proceedings of the National Academy of Sciences 89 (1992) 3586-3590
41. 2+-ATPase. Glycobiology 10 (2000) 773-779
42. Lee A.G. A calcium pump made visible. Current Opinion in Structural Biology 12 (2002) 547-554
43. Leskinen M.J., Kovanen P.T., and Lindstedt K.A. Regulation of smooth muscle cell growth, function and death in vitro by activated mast cells-A potential mechanism for the weakening and rupture of atherosclerotic plaques. Biochemical Pharmacology 66 (2003) 1493-1498
44. 2+) ATPase of the human erythrocyte membrane. Biochimica and Biophysica Acta 598 (1980) 472-485
45. Lindahl U., Lidholt K., Spillmann D., and Kjellén L. More to "heparin" than anticoagulation. Thrombosis Research 75 (1994) 1-32
46. Liu Z., and Armant D.R. Lysophosphatidic acid regulates murine blastocyst development by transactivation of receptors for heparin-binding EGF-like growth factor. Experimental Cell Research 296 (2004) 317-326
47. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. The Journal of Biological Chemistry 193 (1951) 265-275
48. Marcum J.A., and Rosennberg R.D. In: Lane D.A., and Lindahl U. (Eds). Heparin (1989), CRC Press Inc., Boca Raton, FL 275-294
49. Mauger J., Claret M., Pietri F., and Hilly M. Hormonal regulation of inositol 1,4,5 triphosphate receptor in rat liver. The Journal of Biological Chemistry 264 (1989) 8821-8826
50. McCaffrey T.A., Falcone D.J., and Du B. Transforming growth factor-β1 is a heparin binding protein: Identification of putative heparin-binding and isolation of heparins with varying affinity for TGF-β1. Journal of Cellular Physiology 152 (1992) 430-440
51. 2+ store-operated and-independent ionic currents in insulin-secreting HIT-T15 cell mouse pancreatic beta-cells. Journal of Membrane Biology 197 (2004) 59-70
52. 2+-occluded state. Biochimica and Biophysica Acta 1708 (2005) 411-419
53. Mousa S.A. Antithrombotics in thrombosis and cancer. Expert Reviews in Cardiovascular Therapy 1 (2003) 283-291
54. 2+ dependent fashion and modulate its catalytic activity. Biochemistry 42 (2003) 13091-13098
55. 2+-ATPase. Journal of Molecular and Cellular Cardiology 24 (1991) 233-242
56. Peterson G.L. A simplification of the protein assay method of Lowry e cols, which is more generally applicable. Analytical Biochemistry 83 (1977) 346-356
57. Pukac L.A., Castellot J.J.J.R., Wright T.C.J.R., Caleb B.L., and Karnovsky M.J. Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells. Cell Regulation 1 (1990) 435-443
58. Redini F., Tixier J.-M., Petitou M., Choay J., Robert L., and Hornebeck W. Inhibition of leucocyte elastase by heparin and its derivatives. Biochemical Journal 252 (1988) 515-519
59. Rega A.F., Garrahan P.J., Barrabin H., Horenstein A., and Rossi J.P. In: Mukohata Y., and Packer L. (Eds). Calcium flux across biomembranes (1979), Academic Press, New York 67-76
60. 2+-ATPase pump. The Journal of Biological Chemistry 280 (2005) 37195-37203
61. 2+ release from the terminal cysterns of skeletal muscle sarcoplasmic reticulum. FEBS Letters 188 (1985) 77-80
62. +: Modulation by sulfated polysaccharides and trifluoperazine. Journal of Neurochemistry 66 (1996) 772-778
63. 2+-ATPase from human red cell membranes by calmodulin ATP and partial proteolysis. Biochimica and Biophysica Acta 858 (1986) 21-30
64. Ruggiero J., Vieira R.P., and Mourão P.A.S. Increased calcium affinity of a fucosylated chondroitin sulfate from sea cucumber. Carbohydrate Research 256 (1994) 275-287
65. Schatzmann H.J. Dependence on calcium concentration and stoichiometry of the calcium pump in human red cells. Journal of Physiology (London) 235 (1973) 551-569
66. Schatzmann H.J. The plasma membrane calcium pump of erythrocytes and other animal cells. In: Carafoli E. (Ed). Membrane transport of calcium (1982), Academic Press, New York 41-88
67. 2+/calmodulin-dependent membrane-associated kinase CASK. The Journal of Biological Chemistry 278 (2003) 9778-9783
68. Schuh K., Uldrijan S., Telkamp M., Rothlein N., and Neyses L. The plasma membrane calmodulin-dependent calcium pump: A major regulator of nitric oxide synthase I. The Journal of Cell Biology 155 (2001) 201-205
69. Schwarzenbach G., Senn H., and Anderegg C. Komplexone XXIX. Ein grosses chelateffekt besonderer. Helvetica Chimica Acta 40 (1957) 1886-1900
70. 2+ exchanger and reduce the cytosolic calcium of smooth muscle cell lines. The Journal of Biological Chemistry 277 (2002) 48227-48233
71. 2+-ATPase of skeletal-muscle sarcoplasmic reticulum. Biochemical Journal 361 (2002) 277-286
72. Sorenson M.M., Coelho H.S.L., and Reuben J.P. Caffeine inhibition of calcium accumulation by sarcoplasmic reticulum in mammalian skinned fibers. Journal of Membrane Biology 90 (1986) 219-230
73. Strehler E.E., and Zacharias D.A. Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. Physiological Reviews 81 (2001) 21-50
74. 3 receptor function. Cell 73 (1993) 1411-1422
75. 2+ pump and its control by anions and curcumin in skeletal and cardiac sarcoplasmic reticulum. The Journal of Biological Chemistry 277 (2002) 13900-13906
76. Toledo O.M., and Dietrich C.P. Tissue specific distribution of sulfated mucopolysaccharides in mammals. Biochimica and Biophysica Acta 498 (1977) 114-122
77. Töpfer-Petersen E., Calvette J.J., Sanz L., and Sinowatz F. Carbohydrate and heparin-binding proteins in mammalian fertilization. Andrologia 27 (1995) 303-324
78. Vieira R.P., Mulloy B., and Mourão P.A.S. Structure of a fucose branched chondroitin sulphate from sea cucumber: Evidence for the presence of 3-o-sulfo-beta-d-glucuronosyl residues. The Journal of Biological Chemistry 266 (1991) 13530-13536
79. Worley P.F., Baraban J.M., Supattapone S., Wilson V., and Snyder S.H. Characterization of inositol triphosphate receptor binding in brain regulation by pH and calcium. The Journal of Biological Chemistry 262 (1987) 12132-12136
80. Yanagishita M., and Hascall V. Cell surface heparan sulfate proteoglycans. The Journal of Biological Chemistry 267 (1992) 9451-9454
81. Yayon A., Klagsburn M., Esko J.D., Leder P., and Onitiz D.M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64 (1991) 841-848
82. 2+-ATPase associates with the cytoskeleton in activated platelets through a PDZ-binding domain. The Journal of Biological Chemistry 276 (2001) 14704-14709
83. 2+ ATPase from porcine brain synaptosome. Glycoconjugate Journal 19 (2003) 373-378
84. 2+ release and contraction in pulmonary artery myocytes. Cell Calcium 35 (2004) 345-355